A sol particle homogeneous immunoassay for measuring serum cystatin C

Clinical Biochemistry

Volumn 37, Issue 1, 2004, Pages 27-35

  Tanaka, Mutsumi ^a   Matsuo, Kenji ^a   Enomoto, Masayasu ^a   Mizuno, Koji ^a  

^a Azwell Inc   (Japan)

Author keywords

Colloidal gold; Cystatin C; Glomerular filtration rate; Homogeneous immunoassay; Sol particle immunoassay

Indexed keywords

ANTICOAGULANT AGENT; BILIRUBIN; CYSTATIN C; HEMOGLOBIN; RHEUMATOID FACTOR;

ACCURACY; ANALYTIC METHOD; ARTICLE; CORRELATION ANALYSIS; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VALIDATION PROCESS;

EID: 0347481479     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2003.08.001     Document Type: Article

References (36)

1. Grubb A., Löfberg H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc. Natl. Acad. Sci. U.S.A. 79:1982;3024-3027.
2. Barret A.J., Davies M.E., Grubb A. The place of human gamma-trace (cystatin C) among the cysteine proteinase inhibitors. Biochem. Biophys. Res. Commun. 120:1984;631-636.
3. Barrt A.J., Fritz H., Grubb A.et al. Nomenclature and classification of the proteins homologous with chicken cystatin. Biochem. J. 236:1986;312.
4. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin. Nephrol. 38:1992;S20-S27.
5. Abrahamson M., Olafsson I., Palsdttir A.et al. Structure and expression of the human cystatin C gene. Biochem. J. 268:1990;287-294.
6. Newman D.J., Thakkar H., Edwards R.G.et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 47:1995;312-318.
7. Kyhse-Andersen J., Schmidt C., Nordin G.et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin. Chem. 40:1994;1921-1926.
8. Grubb A., Simonsen O., Sturfelt G., Truedsson L., Thysell H. Serum concentration of cystatin C, factor D and beta2-microglobulin as a measure of glomerular filtration rate. Acta Med. Scand. 218:1985;499-503.
9. Randers E., Kristensen J.H., Erlandsen E.J., Danielsen H. Serum cystatin C as a marker of the renal function. Scand. J. Clin. Lab. Invest. 58:1998;585-592.
10. Newman D.J., Thakkar H., Edwards R.G.et al. Serum cystatin C: a replacement for creatinine as a biochemical marker for GFR. Kidney Int. 46:1994;S20-S21.
11. Nilsson-Ehle P., Grubb A. New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int. 47:1994;S17-S19.
12. Fliser D., Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am. J. Kidney Dis. 37:2001;79-83.
13. Randers E., Erlandsen E.J., Pedersen O.L., Hasling C., Danielsen H. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin. Nephrol. 54:2000;203-209.
14. Meir P., Froidevaux C., Dayer E., Blanc E. Cystatin C concentration and glomerular filtration rate. Lancet. 357:2001;634-635.
15. Herget-Rosenthal S., Trabold S., Pietruck F., Heemann U., Philipp T., Kribben A. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am. J. Nephrol. 20:2000;97-102.
16. Coll E., Botey A., Alwarez L.et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am. J. Kidney Dis. 36:2000;29-34.
17. Löfberg H., Grubb A.O. Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. Scand. J. Clin. Lab. Invest. 39:1979;619-626.
18. Pergande M., Jung K. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Clin. Chem. 39:1993;1885-1890.
19. Poulik M.D., Perry D.J., Vokac E., Sekine T. Post-gamma globulin: II. Radioimmunoassay determination of levels of post-gamma globulin and beta2-microglobulin. Clin. Chem. Acta. 128:1983;249-260.
20. Ishiguro H., Ohkubo I., Mizokami M., Titani K., Sasaki M. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma. 8:1989;303-313.
21. Collé A., Tavera C., Prévot D.et al. Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidinbiotin ELISA assay for its measurement. J. Immunoassay. 13:1992;47-60.
22. Mussap M., Ruzzante N., Varagnolo M., Plebani M. Quantitative automated particle-enhanced immunonephelometric assay for the routine measurement of human cystatin C. Clin. Chem. Lab. Med. 36:1998;859-865.
23. Finney H., Newman D.J., Gruber W., Merle P., Price C.P. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Dade Behring nephelometer systems (BNA, BN II). Clin. Chem. 43:1997;1016-1022.
24. Uhlmann E., Hock K.G., Issitt C.et al. Reference intervals for plasma cystatin C in healthy volunteers and renal patients, as measured by the Dade Behring BN II system, and correlation with creatinine. Clin. Chem. 47:2001;2031-2033.
25. Erlandsen E.J., Randers E., Kristensen J.H. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring nephelometer II system. Scand. J. Clin. Lab. Invest. 59:1999;1-8.
26. Erlandsen E.J., Randers E., Kristensen J.H. Reference interals for serum cystatin C and serum creatinine in adults. Clin. Chem. Lab. Med. 36:1998;393-397.
27. Bökenkamp A., Domanetzki M., Zinc R., Schumann G., Byrd D., Brodehl J. Cystatin C - a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 101:1998;875-881.
28. Demirtas S., Bozbas A., Akbay A., Yavuz Y., Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin. Chim. Acta. 311:2001;81-89.
29. Leuvering J.H., Thal P.J., Van der Waart M., Schuurs A.H. A sol particle agglutination assay for human chorionic gonadotrophin. J. Immunol. Methods. 45:1981;183-194.
30. Wielaard F., Denissen A., van der Veen L., Rutjes I. A sol-particle immunoassay for determination of anti-rubella antibodies; development and clinical validation. J. Virol. Methods. 17:1987;149-158.
31. De Roe C., Courtoy P.J., Baudhuin P. A model of protein-colloidal gold interactions. J. Histochem. Cytochem. 35:1987;1191-1198.
32. Jpn J clinical laboratory automation. Performance test manual of the daily clinical test. JJCLA. 27(Suppl. 1):2002.
33. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:1986;307-310.
34. Tonks D.B. A study of accuracy and precision of chemistry determinations in 170 canadian laboratories. Clin. Chem. 9:1963;217-233.
35. Finney H., Newman D.J., Price C.P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann. Clin. Biochem. 37:2000;49-59.
36. Norlund L., Fex G., Lanke J.et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta2-microglobulin/cyctatin C-ratio. Scand. J. Clin. Lab. Invest. 57:1997;463-470.